Correlation Between ImmuPharma PLC and Octopus Aim

Can any of the company-specific risk be diversified away by investing in both ImmuPharma PLC and Octopus Aim at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ImmuPharma PLC and Octopus Aim into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ImmuPharma PLC and Octopus Aim Vct, you can compare the effects of market volatilities on ImmuPharma PLC and Octopus Aim and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ImmuPharma PLC with a short position of Octopus Aim. Check out your portfolio center. Please also check ongoing floating volatility patterns of ImmuPharma PLC and Octopus Aim.

Diversification Opportunities for ImmuPharma PLC and Octopus Aim

0.28

Correlation Coefficient

ImmuPharma PLC  Octopus Aim

Modest diversification

The 3 months correlation between ImmuPharma and Octopus is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding ImmuPharma PLC and Octopus Aim Vct in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Octopus Aim Vct and ImmuPharma PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ImmuPharma PLC are associated (or correlated) with Octopus Aim. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Octopus Aim Vct has no effect on the direction of ImmuPharma PLC i.e., ImmuPharma PLC and Octopus Aim go up and down completely randomly.

Pair Corralation between ImmuPharma PLC and Octopus Aim

Assuming the 90 days trading horizon ImmuPharma PLC is expected to generate 15.32 times more return on investment than Octopus Aim. However, ImmuPharma PLC is 15.32 times more volatile than Octopus Aim Vct. It trades about 0.03 of its potential returns per unit of risk. Octopus Aim Vct is currently generating about -0.05 per unit of risk. If you would invest  298.00  in ImmuPharma PLC on October 18, 2024 and sell it today you would lose (8.00) from holding ImmuPharma PLC or give up 2.68% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

ImmuPharma PLC  vs.  Octopus Aim Vct

ImmuPharma PLC

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in ImmuPharma PLC are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, ImmuPharma PLC exhibited solid returns over the last few months and may actually be approaching a breakup point.

Octopus Aim Vct

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Octopus Aim Vct are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical and fundamental indicators, Octopus Aim is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with ImmuPharma PLC and Octopus Aim

The main advantage of trading using opposite ImmuPharma PLC and Octopus Aim positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ImmuPharma PLC position performs unexpectedly, Octopus Aim can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Octopus Aim will offset losses from the drop in Octopus Aim's long position.

The idea behind ImmuPharma PLC and Octopus Aim Vct pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.